Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000698529 | SCV000827197 | pathogenic | Rubinstein-Taybi syndrome due to CREBBP mutations | 2018-04-26 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing first 24 nucleotides of exon 1 of the CREBBP gene (c.-1380_24del), which includes the initiator codon. This is expected to result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with CREBBP-related disease. Loss-of-function variants in CREBBP are known to be pathogenic (PMID: 17052327, 18792986). For these reasons, this variant has been classified as Pathogenic. |